Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-21-001299
Filing Date
2021-02-08
Accepted
2021-02-08 10:33:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 6823
  Complete submission text file 0000315066-21-001299.txt   8387
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 043532603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 2280 INWOOD ROAD DALLAS TX 75235
Business Address 2280 INWOOD ROAD DALLAS TX 75235 (214) 612-0000
Taysha Gene Therapies, Inc. (Subject) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91724 | Film No.: 21599841
SIC: 2836 Biological Products, (No Diagnostic Substances)